InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (10 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Frates James M, Director. Director active across 2 companies, notably Sage Therapeutics, Inc.. Aggregated, 25 reports have been published. Split: 2 buys · 10 sells. Total volume traded: €1.6m. Activity tracked since 16 June 2021. The latest transaction was disclosed on 18 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Frates James M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
22,807 shares0Common StockSEC:0001193125-26-359679:0
95,990 shares0Common StockSEC:0001193125-26-098438:0
7,909 shares@ US$14.52164.4% of flowCommon StockSEC:0001193125-26-091438:0
3,557 shares@ US$14.64632.0% of flowCommon StockSEC:0001193125-26-037553:0
3,326 shares@ US$11.11061.4% of flowCommon StockSEC:0001193125-26-007669:0
10,558 shares@ US$14.64776.5% of flowCommon StockSEC:0001193125-25-228341:0
2,845 sharesCommon StockSEC:0000950170-25-100653:0
10,896 shares@ US$3.46971.8% of flowCommon StockSEC:0000950170-25-049581:0
68,420 shares0Common StockSEC:0000950170-25-036707:0
40,000 shares@ US$2.53424.8% of flowCommon StockSEC:0000950170-24-106910:0
Canonical exit: 11 Dec 2024 (T+90)
18,165 shares@ US$6.886.1% of flowCommon StockSEC:0000950170-24-104191:0
91,180 shares0Common StockSEC:0000950170-24-045698:0
1,792 shares@ US$18.72791.6% of flowCommon StockSEC:0000950170-24-027918:0
40,000 shares0Common StockSEC:0000950170-24-022434:0
2,716 shares@ US$16.32812.1% of flowCommon StockSEC:0000950170-24-003984:0
11,072 shares0Common StockSEC:0000950170-23-058113:0
18,165 shares@ US$6.886.1% of flowCommon StockSEC:0000950170-23-044381:0
32,500 shares@ US$6.8810.9% of flowCommon StockSEC:0000899243-23-013289:0
19,482 shares0Common StockSEC:0000899243-23-011781:0
32,500 shares@ US$6.8811.1% of flowCommon StockSEC:0000899243-23-009602:0
30,796 shares@ US$31.859348.9% of flowCommon StockSEC:0000899243-23-009168:0
1,836 shares@ US$36.07893.3% of flowCommon StockSEC:0000899243-23-001523:0
822 shares@ US$36.78881.5% of flowCommon StockSEC:0000899243-23-001523:1
5,000 shares@ US$6.881.7% of flowCommon StockSEC:0000899243-23-000755:0
1,810 shares@ US$55.102100.0% of flowCommon StockSEC:0001562180-21-004347:0
Canonical exit: 14 Sept 2021 (T+90)
25 of 25 declarations
About Frates James M
FRATES JAMES M is an Administrateur and has 24 filings in total. Across the 24 sampled filings, the activity runs from 2021-06-17 to 2026-03-09, with EUR 174648 of buys and EUR 1430060 of sells, and the most frequent transaction nature is Cession. He is also Chief Financial Officer at Amylyx Pharmaceuticals, Inc. and Director at Sage Therapeutics, Inc.
